A rare clinical case of multifocal retinal vasoproliferative tumor: Diagnosis and treatment tactics
https://doi.org/10.34215/1609-1175-2025-3-94-99
Abstract
Objective. This article presents a clinical case of multifocal vasoproliferative tumor (VPT) of the retina and its successful treatment. In March 2020, a 28-year-old man with progressive deterioration of vision in the left eye referred to the Khabarovsk Branch of Fyodorov Eye Microsurgery Federal State Institution. Vis = OD 1.0; OS = 0.1 n/c. Anterior-posterior axis: OD = 23.11 mm, OS – 22.61 mm. Intraocular pressure (IOP): OD = 18 mm Hg, OS = 16 mm Hg. In the macular area of the left eye, high retinal edema and isolated deposits of hard retinal exudates were determined. In the equator and periphery, confluent fields of deposits of hard exudates with areas of capillary vascular lacunae with massive exudation were observed. Optical coherence tomography detected a high macular edema with detachment of the pigment and neuroepithelium. B-scanning of the vitreous cavity found no neoplasms of the eye choroid. The diagnosis of vasoproliferative tumor of the retina was established. An intravitreal Ozurdex implant was injected in the left eye. One month later, moderate reduction of macular edema and the subretinal fluid layer occurred. At the second stage, an incomplete panretinal laser coagulation of the retina was performed. Two weeks later, transpupillary thermotherapy (TTT) of the VPT localization zones was performed as the main treatment stage. One month later, a significant reduction in edema and the formation of fibrosis of the VPT were observed. The best-corrected visual acuity (BCVA) of the left eye increased significantly – to 0.9. The IOP level was 19 mm Hg. Three months after TTT, the BCVA of the left eye was 1.0. In the macular area, all VPT fragments were subject to fibrosis; in the parafoveal area, flat detachment of the neuroepithelium, up to 20 μm, and isolated hard exudates remained. Thenanatomical structure of the macular area was restored.
About the Authors
I. Z. KravchenkoRussian Federation
Igor Z. Kravchenko, ophthalmologist of the Laser Surgery Department
211 Tikhookeanskaya str., Khabarovsk, 680033, Russia
E. L. Sorokin
Russian Federation
Khabarovsk
O. V. Kolenko
Russian Federation
Khabarovsk
References
1. Baines PS, Hiscott PS, McLeod D. Posterior non-vascularized proliferative extraretinopathy and peripheral nodular retinal telangiectasis. Trans Ophthalmol Soc UK. 1982;102(Pt 4):487–91.
2. Shields CL, Shields JA, Barrett J, De Potter P. Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients. Arch Ophthalmol. 1995;113(5):615–23. doi: 10.1001/archopht.1995.01100050083035
3. Kravchenko IZ, Khudyakov AYu, Sorokin EL. Five-year experience and effectiveness of treatment of retinal vasoproliferative tumors. Sovremennye Tekhnologii Oftal'mologii. 2017;(1):145–147 (In Russ.).
4. Neroev VV, Kiseleva TN, Novikova AYu, Ryabina MV, Ilyukhin PA, Ramazanova KA. Differential diagnosis of retinal capillary hemangiomas and vasoproliferative tumors. Russian Ophthalmological Journal. 2019;12(2):39–47 (In Russ.). doi: 10.21516/2072-0076-2019-12-2-39-47
5. Lando L, P Cialdini A, P Avila M. Retinal Vasoproliferative Tumor in Congenital Ocular Toxoplasmosis. Ophthalmol Retina. 2019;3(10):910. doi: 10.1016/j.oret.2019.05.011
6. Manayath GJ, Namburi P, Periasamy S, Kale JA, Narendran V, Ganesh A. A novel mutation in the NR2E3 gene associated with Goldmann-Favre syndrome and vasoproliferative tumor of the retina. Mol Vis. 2014;20:724–31.
7. Uner OE, Rao P, Hubbard GB 3rd. Reactivation of Retinopathy of Prematurity in Adults and Adolescents. Ophthalmol Retina. 2020;4(7):720–727. doi: 10.1016/j.oret.2020.02.001
8. Magaramov DA, Volodin PL, Loginov RA. Choroidal and retinal tumors: diagnostic and treatment modalities. Modern Technologies in Ophthalmology. 2019;(1):373–377 (In Russ.). doi: 10.25276/2312-4911-2019-1-373-377
9. Gorodetskaya YuB, Yarovoy AA, Gorshkov IM, Loginov RA. Vasoproliferative retinal tumors. Current approach to treatment. Fyodorov Journal of Ophthalmic Surgery. 2021;(2):86–93 (In Russ.). doi: 10.25276/0235-4160-2021-2-86-93
10. Hussain RN, Jmor F, Damato B, et al. Verteporfin photodynamic therapy for the treatment of retinal vasoproliferative tumors. Ophthalmology. 2015;122: 2361–2363. doi: 10.1097/01.iae.0000238554.61165.fd
11. Yarovoy AA, Gorshkov IM, Gorodetskaya YuB, Loginov RA. Brachytherapy as a treatment of a vasoproliferative retinal tumor. Fyodorov Journal of Ophthalmic Surgery. 2022;(2):15–19 (In Russ.). doi: 10.25276/0235-4160-2022-2-15-19
12. Gorodetskaya YB, Yarovoy AA, Gorshkov IM. The surgical management of vasoproliferative tumour. Sovremennye Tekhnologii Oftal'mologii. 2020;(3):96–97 (In Russ.). doi: 10.25276/2312-4911-2020-3-96-97
13. Yarovoy AA, Magaramov DA, Gavrilova NA, Loginov RA, Yarovaya VA, Korobov EN. Various approaches to the treatment of vasoproliferative tumor and their results. Sovremennye Tekhnologii Oftal'mologii. 2018;(1):448–451 (In Russ.).
14. Walinjkar JA, Sharma US, Rishi P, Rishi E, Gopal L, Sharma T. Clinical features and treatment outcomes of vasoproliferative tumors in Indian participants. Indian J Ophthalmol. 2018;66(2):246–251. doi: 10.4103/ijo.IJO_210_17
15. Kumar V, Shaikh Md N. Refractile Deposits in Vasoproliferative Tumor after Ablation Therapy. Ophthalmol Retina. 2020;4(4):424. doi: 10.1016/j.oret.2019.12.009
Review
For citations:
Kravchenko I.Z., Sorokin E.L., Kolenko O.V. A rare clinical case of multifocal retinal vasoproliferative tumor: Diagnosis and treatment tactics. Pacific Medical Journal. 2025;(3):94-99. (In Russ.) https://doi.org/10.34215/1609-1175-2025-3-94-99





























